Most Popular | BioMedReports.com

FDA Approves Genentech’s Cotellic™ in Combination With Zelboraf®; FORUM Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program

Print

E-mail

By Josh Gee
Wednesday, 11 November 2015 20:07
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 11, 2015.
Read more...

MediciNova Receives Notice of Allowance for New Patent Covering MN-221; FDA Grants TEVA Therapy Designation for SD-809

Print

E-mail

By Mary Davila
Tuesday, 10 November 2015 19:42
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 10, 2015.
Read more...

Capricor Presents Positive Data from the DYNAMIC Clinical Trial; Collegium Announces FDA Tentative Approval for Xtampza(TM) ER

Print

E-mail

By Josh Gee
Monday, 09 November 2015 19:40
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 9, 2015.
Read more...

First Patient Dosed in Clinical Trial of Halozyme's PEGPH20; Rexahn Reports Interim Clinical Data for Archexin(R)

Print

E-mail

By Mary Davila
Thursday, 05 November 2015 20:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 5, 2015.
Read more...

MiMedx Issues Document Related to Misinterpretations of FDA's Proposed Draft Guidance; Genocea Presents Positive Findings from ATLASTM Immuno-Oncology Research Collaboration

Print

E-mail

By Josh Gee
Wednesday, 04 November 2015 20:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 4, 2015.
Read more...

Threshold Pharma Announces Preclinical Data on Combination of Evofosfamide With Immune Checkpoint Inhibitors; Mylan Receives U.S. FTC Clearance for Proposed Acquisition of Perrigo

Print

E-mail

By Mary Davila
Tuesday, 03 November 2015 20:53
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 3, 2015.
Read more...

Merck Receives Therapy Designation from FDA for KEYTRUDA(R); Cellectar Provides Phospholipid Drug Conjugate Platform Development Update

Print

E-mail

By Marilyn Mullen
Monday, 02 November 2015 20:41
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 2, 2015.
Read more...

Analysts review the pros and pitfalls involved in a Pfizer/Allergan megamerger; Repros Therapeutics Announces Cancellation of FDA Advisory Committee Meeting to Review Enclomiphene

Print

E-mail

By Marilyn Mullen
Thursday, 29 October 2015 18:38
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 29, 2015.
Read more...

Gilead Submits NDA to FDA for Fixed-Dose Combination of Sofosbuvir/Velpatasvir; AMAG Pharma Announces 3 Trial Evaluating Feraheme(R)

Print

E-mail

By Mary Davila
Wednesday, 28 October 2015 18:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 28, 2015.
Read more...

Macrocure Announces Results for Phase III Clinical Trial of CureXcell(R); Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF Phase 2

Print

E-mail

By Mary Davila
Tuesday, 27 October 2015 19:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 27, 2015.
Read more...

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 369

Newsletter